Pooled influenza vaccine effectiveness estimates for Australia, 2012-2014

S.G. Sullivan, K.S. Carville, M. Chilver, J.E. Fielding, K.A. Grant, H. Kelly, Avram Levy, N.P. Stocks, S.S. Tempone, Annette Regan

    Research output: Contribution to journalArticle

    10 Citations (Scopus)

    Abstract

    © Cambridge University Press 2016.Data were pooled from three Australian sentinel general practice influenza surveillance networks to estimate Australia-wide influenza vaccine coverage and effectiveness against community presentations for laboratory-confirmed influenza for the 2012, 2013 and 2014 seasons. Patients presenting with influenza-like illness at participating GP practices were swabbed and tested for influenza. The vaccination odds of patients testing positive were compared with patients testing negative to estimate influenza vaccine effectiveness (VE) by logistic regression, adjusting for age group, week of presentation and network. Pooling of data across Australia increased the sample size for estimation from a minimum of 684 to 3,683 in 2012, from 314 to 2,042 in 2013 and from 497 to 3,074 in 2014. Overall VE was 38% [95% confidence interval (CI) 24-49] in 2012, 60% (95% CI 45-70) in 2013 and 44% (95% CI 31-55) in 2014. For A(H1N1)pdm09 VE was 54% (95% CI-28 to 83) in 2012, 59% (95% CI 33-74) in 2013 and 55% (95% CI 39-67) in 2014. For A(H3N2), VE was 30% (95% CI 14-44) in 2012, 67% (95% CI 39-82) in 2013 and 26% (95% CI 1-45) in 2014. For influenza B, VE was stable across years at 56% (95% CI 37-70) in 2012, 57% (95% CI 30-73) in 2013 and 54% (95% CI 21-73) in 2014. Overall VE against influenza was low in 2012 and 2014 when A(H3N2) was the dominant strain and the vaccine was poorly matched. In contrast, overall VE was higher in 2013 when A(H1N1)pdm09 dominated and the vaccine was a better match. Pooling data can increase the sample available and enable more precise subtype- and age group-specific estimates, but limitations remain.
    Original languageEnglish
    Pages (from-to)2317-2328
    JournalEpidemiology and Infection
    Volume144
    Issue number11
    DOIs
    Publication statusPublished - 2016

    Fingerprint

    Influenza Vaccines
    Confidence Intervals
    Vaccines
    Human Influenza
    Meta-Analysis
    Age Groups
    General Practice
    Sample Size
    Vaccination
    Logistic Models

    Cite this

    Sullivan, S. G., Carville, K. S., Chilver, M., Fielding, J. E., Grant, K. A., Kelly, H., ... Regan, A. (2016). Pooled influenza vaccine effectiveness estimates for Australia, 2012-2014. Epidemiology and Infection, 144(11), 2317-2328. https://doi.org/10.1017/S0950268816000819
    Sullivan, S.G. ; Carville, K.S. ; Chilver, M. ; Fielding, J.E. ; Grant, K.A. ; Kelly, H. ; Levy, Avram ; Stocks, N.P. ; Tempone, S.S. ; Regan, Annette. / Pooled influenza vaccine effectiveness estimates for Australia, 2012-2014. In: Epidemiology and Infection. 2016 ; Vol. 144, No. 11. pp. 2317-2328.
    @article{e4fefdb20b8443feab7f20c5831f241a,
    title = "Pooled influenza vaccine effectiveness estimates for Australia, 2012-2014",
    abstract = "{\circledC} Cambridge University Press 2016.Data were pooled from three Australian sentinel general practice influenza surveillance networks to estimate Australia-wide influenza vaccine coverage and effectiveness against community presentations for laboratory-confirmed influenza for the 2012, 2013 and 2014 seasons. Patients presenting with influenza-like illness at participating GP practices were swabbed and tested for influenza. The vaccination odds of patients testing positive were compared with patients testing negative to estimate influenza vaccine effectiveness (VE) by logistic regression, adjusting for age group, week of presentation and network. Pooling of data across Australia increased the sample size for estimation from a minimum of 684 to 3,683 in 2012, from 314 to 2,042 in 2013 and from 497 to 3,074 in 2014. Overall VE was 38{\%} [95{\%} confidence interval (CI) 24-49] in 2012, 60{\%} (95{\%} CI 45-70) in 2013 and 44{\%} (95{\%} CI 31-55) in 2014. For A(H1N1)pdm09 VE was 54{\%} (95{\%} CI-28 to 83) in 2012, 59{\%} (95{\%} CI 33-74) in 2013 and 55{\%} (95{\%} CI 39-67) in 2014. For A(H3N2), VE was 30{\%} (95{\%} CI 14-44) in 2012, 67{\%} (95{\%} CI 39-82) in 2013 and 26{\%} (95{\%} CI 1-45) in 2014. For influenza B, VE was stable across years at 56{\%} (95{\%} CI 37-70) in 2012, 57{\%} (95{\%} CI 30-73) in 2013 and 54{\%} (95{\%} CI 21-73) in 2014. Overall VE against influenza was low in 2012 and 2014 when A(H3N2) was the dominant strain and the vaccine was poorly matched. In contrast, overall VE was higher in 2013 when A(H1N1)pdm09 dominated and the vaccine was a better match. Pooling data can increase the sample available and enable more precise subtype- and age group-specific estimates, but limitations remain.",
    author = "S.G. Sullivan and K.S. Carville and M. Chilver and J.E. Fielding and K.A. Grant and H. Kelly and Avram Levy and N.P. Stocks and S.S. Tempone and Annette Regan",
    year = "2016",
    doi = "10.1017/S0950268816000819",
    language = "English",
    volume = "144",
    pages = "2317--2328",
    journal = "Epidemiology and Infection",
    issn = "0950-2688",
    publisher = "Cambridge University Press",
    number = "11",

    }

    Sullivan, SG, Carville, KS, Chilver, M, Fielding, JE, Grant, KA, Kelly, H, Levy, A, Stocks, NP, Tempone, SS & Regan, A 2016, 'Pooled influenza vaccine effectiveness estimates for Australia, 2012-2014' Epidemiology and Infection, vol. 144, no. 11, pp. 2317-2328. https://doi.org/10.1017/S0950268816000819

    Pooled influenza vaccine effectiveness estimates for Australia, 2012-2014. / Sullivan, S.G.; Carville, K.S.; Chilver, M.; Fielding, J.E.; Grant, K.A.; Kelly, H.; Levy, Avram; Stocks, N.P.; Tempone, S.S.; Regan, Annette.

    In: Epidemiology and Infection, Vol. 144, No. 11, 2016, p. 2317-2328.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Pooled influenza vaccine effectiveness estimates for Australia, 2012-2014

    AU - Sullivan, S.G.

    AU - Carville, K.S.

    AU - Chilver, M.

    AU - Fielding, J.E.

    AU - Grant, K.A.

    AU - Kelly, H.

    AU - Levy, Avram

    AU - Stocks, N.P.

    AU - Tempone, S.S.

    AU - Regan, Annette

    PY - 2016

    Y1 - 2016

    N2 - © Cambridge University Press 2016.Data were pooled from three Australian sentinel general practice influenza surveillance networks to estimate Australia-wide influenza vaccine coverage and effectiveness against community presentations for laboratory-confirmed influenza for the 2012, 2013 and 2014 seasons. Patients presenting with influenza-like illness at participating GP practices were swabbed and tested for influenza. The vaccination odds of patients testing positive were compared with patients testing negative to estimate influenza vaccine effectiveness (VE) by logistic regression, adjusting for age group, week of presentation and network. Pooling of data across Australia increased the sample size for estimation from a minimum of 684 to 3,683 in 2012, from 314 to 2,042 in 2013 and from 497 to 3,074 in 2014. Overall VE was 38% [95% confidence interval (CI) 24-49] in 2012, 60% (95% CI 45-70) in 2013 and 44% (95% CI 31-55) in 2014. For A(H1N1)pdm09 VE was 54% (95% CI-28 to 83) in 2012, 59% (95% CI 33-74) in 2013 and 55% (95% CI 39-67) in 2014. For A(H3N2), VE was 30% (95% CI 14-44) in 2012, 67% (95% CI 39-82) in 2013 and 26% (95% CI 1-45) in 2014. For influenza B, VE was stable across years at 56% (95% CI 37-70) in 2012, 57% (95% CI 30-73) in 2013 and 54% (95% CI 21-73) in 2014. Overall VE against influenza was low in 2012 and 2014 when A(H3N2) was the dominant strain and the vaccine was poorly matched. In contrast, overall VE was higher in 2013 when A(H1N1)pdm09 dominated and the vaccine was a better match. Pooling data can increase the sample available and enable more precise subtype- and age group-specific estimates, but limitations remain.

    AB - © Cambridge University Press 2016.Data were pooled from three Australian sentinel general practice influenza surveillance networks to estimate Australia-wide influenza vaccine coverage and effectiveness against community presentations for laboratory-confirmed influenza for the 2012, 2013 and 2014 seasons. Patients presenting with influenza-like illness at participating GP practices were swabbed and tested for influenza. The vaccination odds of patients testing positive were compared with patients testing negative to estimate influenza vaccine effectiveness (VE) by logistic regression, adjusting for age group, week of presentation and network. Pooling of data across Australia increased the sample size for estimation from a minimum of 684 to 3,683 in 2012, from 314 to 2,042 in 2013 and from 497 to 3,074 in 2014. Overall VE was 38% [95% confidence interval (CI) 24-49] in 2012, 60% (95% CI 45-70) in 2013 and 44% (95% CI 31-55) in 2014. For A(H1N1)pdm09 VE was 54% (95% CI-28 to 83) in 2012, 59% (95% CI 33-74) in 2013 and 55% (95% CI 39-67) in 2014. For A(H3N2), VE was 30% (95% CI 14-44) in 2012, 67% (95% CI 39-82) in 2013 and 26% (95% CI 1-45) in 2014. For influenza B, VE was stable across years at 56% (95% CI 37-70) in 2012, 57% (95% CI 30-73) in 2013 and 54% (95% CI 21-73) in 2014. Overall VE against influenza was low in 2012 and 2014 when A(H3N2) was the dominant strain and the vaccine was poorly matched. In contrast, overall VE was higher in 2013 when A(H1N1)pdm09 dominated and the vaccine was a better match. Pooling data can increase the sample available and enable more precise subtype- and age group-specific estimates, but limitations remain.

    U2 - 10.1017/S0950268816000819

    DO - 10.1017/S0950268816000819

    M3 - Article

    VL - 144

    SP - 2317

    EP - 2328

    JO - Epidemiology and Infection

    JF - Epidemiology and Infection

    SN - 0950-2688

    IS - 11

    ER -

    Sullivan SG, Carville KS, Chilver M, Fielding JE, Grant KA, Kelly H et al. Pooled influenza vaccine effectiveness estimates for Australia, 2012-2014. Epidemiology and Infection. 2016;144(11):2317-2328. https://doi.org/10.1017/S0950268816000819